ImmusanT is committed to the discovery and clinical development of innovative therapies for celiac disease, an autoimmune-like condition caused by an immune reaction to gluten proteins. ImmusanT’s approach is based on restoring immune tolerance, or non-responsiveness, to gluten and thus offers a therapeutic promise that will improve symptoms and quality of life for patients without the burden of a lifelong gluten-free diet.
